Showing results (391-400 of 928) with videos related to

Sort By:
Pageof 93
Evidence-Based Complementary and Alternative Medicine : Ecam|May 22, 2013
The treatment of depressed chinese americans using qigong in a health care setting: a pilot studyAlbert Yeung, Lauren E Slipp, Jolene Jacquart, et al.
Addictive Behaviors Reports|February 17, 2018
Anterior insula activation during inhibition to smoking cues is associated with ability to maintain tobacco abstinenceJodi M Gilman, Milena Radoman, Randi M Schuster, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 10, 2002
Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trialShamsah B Sonawalla, Amy H Farabaugh, Vinita M Leslie, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2002
Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trialShamsah B Sonawalla, Amy H Farabaugh, Vinita M Leslie, et al.
Human Psychopharmacology|June 20, 2006
Differences in cognitive factors between "true drug" versus "placebo pattern" response to fluoxetine as defined by pattern analysisAmy H Farabaugh, Shamsah B Sonawalla, Maurizio Fava, et al.
Depression and Anxiety|July 11, 2007
Long-term tolerability and effectiveness of duloxetine in the treatment of major depressive disorderDavid L Dunner, Michael Wilson, Maurizio Fava, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|August 31, 2007
The efficacy and tolerability of duloxetine in the treatment of anxious versus non-anxious depression: a post-hoc analysis of an open-label outpatient studyMaurizio Fava, James M Martinez, John Greist, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 21, 2018
What is the overlap between subjective and objective cognitive impairments in MDD?Maurizio Fava, Atul R Mahableshwarkar, William Jacobson, et al.
Psychiatry Research|August 30, 2008
Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorderGeorge I Papakostas, Patrick McGrath, Jonathan Stewart, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|June 15, 2007
Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depressionAndrew Krystal, Maurizio Fava, Robert Rubens, et al.
Pageof 93